Earnings Previews: Caterpillar, Exxon Mobil, McDonald’s, Pfizer, UPS
- By247wallst-
Five companies, including three Dow Jones industrials, are on deck to report quarterly earnings before markets open on Tuesday.
Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
Five companies, including three Dow Jones industrials, are on deck to report quarterly earnings before markets open on Tuesday.
UBS downgraded Pfizer Inc (NYSE:PFE) to Neutral from Buy and cut its price target to $47.00 from $55.00 on Covid-related headwinds and its view that the company's pipeline is...
By Sam Boughedda Pfizer (NYSE:PFE) was downgraded to Neutral from Buy with its price target cut to $47 from $55 by UBS analysts on Thursday. The analysts told investors in a...
"Directed Evolution"? Pfizer R&D Exec Says Covid-19 Created In Wuhan, Is 'Cash Cow' For Company A high-level Pfizer employee was caught on undercover camera by Project Veritas when...
"What About The Sudden Deaths?": Pfizer CEO Confronted At Davos Over COVID-19 Vaccine While attention is now firmly shifting towards the scandalous Covid-19 vaccine rollout (and...
Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research Authored by Zachary Stieber via The Epoch Times (emphasis ours), An American doctor is...
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
| Average | 55.40 (+26.51% Upside) |
| High | 75.00 |
| Low | 44.00 |
| Price | 43.79 |
| No. of Analysts | 20 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 47.33 | 48.07 | 47.02 | -0.37 | -0.78% | 259.24K | Toronto | |||
| 8.88 | 8.91 | 8.08 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 0.19 | 0.19 | 0.185 | 0.00 | 0.00% | 0.00 | CSE | |||
| 2.75 | 3.39 | 2.71 | 0.00 | 0.00% | 87.48K | Toronto | |||
| 9.96 | 10.22 | 9.89 | -0.01 | -0.10% | 4.70M | Toronto | |||
| 9.72 | 9.77 | 9.36 | +0.240 | +2.53% | 883.23K | Toronto | |||
| 40.41 | 40.60 | 40.12 | -0.21 | -0.52% | 407.57K | Toronto | |||
| 142.06 | 148.61 | 140.90 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 8.60 | 8.89 | 8.20 | +0.36 | +4.37% | 199.40K | CSE | |||
| 13.72 | 13.76 | 13.60 | +0.04 | +0.29% | 157.95K | Toronto | |||
| 54.00 | 54.33 | 51.69 | +1.42 | +2.70% | 291.48K | Toronto | |||
| 2.53 | 2.54 | 2.385 | +0.1200 | +4.98% | 596.63K | TSXV | |||
| 9.72 | 9.79 | 9.63 | 0.00 | 0.00% | 5.76M | Toronto | |||
| 91.42 | 91.58 | 90.54 | +0.65 | +0.72% | 4.31M | Toronto | |||
| 1.20 | 1.22 | 1.19 | 0.00 | 0.00% | 15.79K | TSXV |